Literature DB >> 69198

Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: beta-glucosidase.

P E Belchetz, J C Crawley, I P Braidman, G Gregoriadis.   

Abstract

An adult with Gaucher's disease was injected with liposomes containing human glucocerebroside: beta-glucosidase. After 13 months of treatment the lower border of the right hepatic lobe and moved up 3 cm, and the left lobe had shrunk. Reduction in the size of the liver was associated with relief of pressure symptoms in the left lower abdomen. Scans obtained after the injection of radiolabelled liposomes suggested improvement in function of the reticuloendothelial system.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69198     DOI: 10.1016/s0140-6736(77)90123-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Cerebroside-beta-glucosidase encapsulation in liposomes for Gaucher's disease treatment revisited.

Authors:  V Korablyov; A Zimran; Y Barenholz
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro.

Authors:  G L Dale; W Kuhl; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 3.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

Review 4.  Severe mental handicap: pathogenesis, treatment, and prevention.

Authors:  M D Crawfurd
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-18

5.  Niemann-Pick disease type B in an Irish family.

Authors:  E Lawlor; G T Besley; P Pierce; I J Temperley
Journal:  Ir J Med Sci       Date:  1981-06       Impact factor: 1.568

6.  Improvement of splenomegaly and pancytopenia by enzyme replacement therapy against type 1 Gaucher disease: a report of sibling cases.

Authors:  K Tsuboi; S Iida; M Kato; Y Hayami; I Hanamura; K Miura; S Harada; H Komatsu; S Banno; A Wakita; M Nitta; R Ueda
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

7.  Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages.

Authors:  Y Sato; E Beutler
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 8.  Alglucerase. A review of its therapeutic use in Gaucher's disease.

Authors:  R Whittington; K L Goa
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

9.  Kinetics and disposition of fluorescein-labelled liposomes in healthy human subjects.

Authors:  H G Eichler; J Senior; A Stadler; S Gasic; P Pfundner; G Gregoriadis
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Studies in vivo of the tissue uptake, cellular distribution and catabolic turnover of exogenous glucocerebrosidase in rat.

Authors:  S Morrone; P G Pentchev; J Baynes; S Thorpe
Journal:  Biochem J       Date:  1981-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.